Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61,216,263
-
Number of holders
-
300
-
Total 13F shares, excl. options
-
59,889,877
-
Shares change
-
+310,199
-
Total reported value, excl. options
-
$3,943,162,300
-
Value change
-
+$28,340,058
-
Put/Call ratio
-
28%
-
Number of buys
-
133
-
Number of sells
-
-163
-
Price
-
$65.87
Significant Holders of Dolby Laboratories, Inc. - Common Stock (DLB) as of Q2 2020
349 filings reported holding DLB - Dolby Laboratories, Inc. - Common Stock as of Q2 2020.
Dolby Laboratories, Inc. - Common Stock (DLB) has 300 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,889,877 shares
of 61,216,263 outstanding shares and own 98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,895,499 shares), JANUS HENDERSON GROUP PLC (4,437,649 shares), Clearbridge Investments, LLC (3,982,690 shares), BlackRock Inc. (3,233,692 shares), ATLANTA CAPITAL MANAGEMENT CO L L C (2,342,526 shares), MACKENZIE FINANCIAL CORP (2,221,533 shares), RENAISSANCE TECHNOLOGIES LLC (1,848,357 shares), DISCIPLINED GROWTH INVESTORS INC /MN (1,285,330 shares), Ceredex Value Advisors LLC (1,260,269 shares), and Bank of New York Mellon Corp (1,126,102 shares).
This table shows the top 300 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.